Health Care & Life Sciences » Biotechnology | EPIRUS Biopharmaceuticals Inc.

EPIRUS Biopharmaceuticals Inc.

EPIRUS Biopharmaceuticals Inc.
Stock Exchange Other OTC
EPS
-
Market Cap
$73.32 K
Shares Outstanding
26.18 M
Public Float
-

Profile

Address
699 Boylston Street
Boston Massachusetts 02116
United States
Employees -
Website http://www.epirusbiopharma.com
Updated 07/08/2019
EPIRUS Biopharmaceuticals, Inc. is a biopharmaceutical company focused on building a pure-play, sustainable and profitable biosimilar business. It focuses on biosimilars, which are biologic drugs that are demonstrated to be highly similar to a previously approved biologic drug, known as a reference product. The company was founded on November 26, 2008 and is headquartered in Boston, MA.

Financials

View All
Created with Highcharts 5.0.14EPIRUS Biopharmaceuticals Inc.Net Income. Fiscal year is January-December. All values USD Thousands.42 04342 04344 32744 32738 61738 61741 84441 84452 18852 18820112012201320142015010k20k30k40k50k60k
Created with Highcharts 5.0.14EPIRUS Biopharmaceuticals Inc.Sales/Revenue. Fiscal year is January-December. All values USD Thousands.8 1848 18412 55012 55014 73114 731447017012011201220132014201502.5k5k7.5k10k12.5k15k17.5k

Jeff Kagy
Vice President-Human Resources & Administration
Kim Seth
Chief Business Officer